Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-014231
Filing Date
2026-03-03
Accepted
2026-03-03 19:02:48
Documents
4
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772582565.html 4  
1 FORM 4 wk-form4_1772582565.xml 4 8150
2 EX-24 poafalcione.htm EX-24 4837
3 GRAPHIC poafalcione001.jpg GRAPHIC 250627
4 GRAPHIC poafalcione002.jpg GRAPHIC 75598
  Complete submission text file 0001628280-26-014231.txt   463823
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Falcione Aaron (Reporting) CIK: 0001859803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 26717785